Dr. Cheng Zhang is an experienced systems biologist, and he has conducted the creation of human pathology atlas and contributed to both human cell atlas project within the Swedish Human Protein Atlas program and the cell atlas within the international Human Cell Atlas program. So far, he has published more than 30 research and review papers in different journals including Science, Cell, Cell Metabolism, PNAS, Nucleic Acids Research, Molecular Systems Biology and Metabolic Engineering. His main research interests including developing and expanding genome-scale metabolic models to other omics level, and applying them into clinic such as investigating the driving factors, biomarkers or potential therapeutic strategies for obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma. His research resulted in the development of a few novel drugs for fatty liver disease and different cancer types.
Dr. Cheng Zhang is an experienced systems biologist, and he has conducted the creation of human pathology atlas and contributed to both human cell atlas project within the Swedish Human Protein Atlas program and the cell atlas within the international Human Cell Atlas program. So far, he has published more than 30 research and review papers in different journals including Science, Cell, Cell Metabolism, PNAS, Nucleic Acids Research, Molecular Systems Biology and Metabolic Engineering. His main research interests including developing and expanding genome-scale metabolic models to other omics level, and applying them into clinic such as investigating the driving factors, biomarkers or potential therapeutic strategies for obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma. His research resulted in the development of a few novel drugs for fatty liver disease and different cancer types.